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aBsTRacT
INTRODUCTION: The widespread use of computed tomog­
raphy (CT) improves detection of pulmonary lesions, which 
are not only detected at an increased rate but also at a 
smaller size. CT­guided lung biopsies are now more fre­
quently used than fluoroscopy­guided lung biopsies. The 
main aim of the present paper was to investigate the out­
come and complications of the biopsies. 
METHODS: We retrospectively collected the results and in­
formation from 520 CT­guided thorax biopsies. All biopsies 
were performed with CT­guided “beam­through” tech­
nique, using a 64­slice CT scanner. 
RESULTS: In 86% of the biopsies, the tissue material was 
found to be sufficient. In 32% of the biopsies, a complica­
tion arose, mostly pneumothorax (30%), but chest drainage 
was needed in only 15% of the 520 cases. Patients with 
more than ten cigarette pack­years had a complication risk 
that was twice as high at that of patients with fewer pack­
years. We found that the risk of pneumothorax increased 
the further the lesion was from the skin surface, the smaller 
the lesions were and when the patient was biopsied in a lat­
eral position. We also found a higher risk of complications 
in females than in males.
CONCLUSIONS: CT­guided biopsy is an excellent tool for 
ana lysing pulmonary lesions. The present study clearly 
shows that the risk of developing a pneumothorax is signifi­
cantly increased among smokers and former smokers with 
more than ten pack­years. 
FUNDING: none.
TRIAL REGISTRATION: not relevant.
Lung cancer is the second most common cancer meas­
ured by the number of new annual cases in men and 
women. The widespread use of CT improves detection 
of pulmonary lesions which are detected at an increased 
rate but also at smaller sizes. Radiologists are therefore 
now attempting to biopsy smaller lesions than in the 
past. Because of this trend, we probably need to accept 
a certain decline in diagnostic success and an increase in 
complication rates because it is occasionally difficult to 
hit these sometimes very small lesions. 
CT­guided lung biopsies are now more frequently 
used than fluoroscopy guidance [1]. All thorax biopsies 
carry a certain risk of complications; most commonly 
pneumothorax and haemoptysis. Although other studies 
have analysed risk factors in CT­guided lung biopsies  
[2­4], no Danish reports on identification of procedure­
related risk factors or complications exist. The present 
study is a retrospective analysis of CT­guided thorax  
biopsies performed at our department with a view to 
determining which risk factors associated with needle 
biopsies. The main purpose of the present article is to 
investigate the outcome of the biopsies with respect to 
diagnostic accuracy, histological and cytological diag­
noses and complications. 
mEThOds 
The study was approved by the 
danish data Protection agency
We retrospectively collected results and information 
about 520 CT­guided thorax biopsies performed at our 
hospital from January to December 2012. Data were col­
lected from the Radiology Information System (RIS), the 
Picture Archiving and Communication System (PACS), 
the Electronic Patient Journal (EPJ) and from WEB Path­
ology (an electronic reporting system for pathological 
findings). 
A total of 562 biopsies had been scheduled. Among 
those, 42 were excluded because the patient’s diagnosis 
was already clear, blood parameters were outside the 
safe levels for undergoing a biopsy, or because patients 
did not show up at the hospital on the day of the biopsy. 
The study included 427 patients (235 males and 192 fe­
males) whose mean age was 67.8 years (range: 22­92 
years). They all underwent a total of 520 biopsies. 
A total of 334 patients (78%) had one biopsy per­
formed, 79 patients (19%) underwent the biopsy 
proced ure twice, and 14 patients (3%) had three bi­
opsies performed.
The majority of biopsies (478) were performed by 
an experienced radiologist (more than 50 CT­guided bi­
opsies prior to the study), and 42 of the biopsies were 
done by radiology residents who were supervised by an 
experienced radiologist.
All biopsies were performed with CT­guided “beam­
through” technique, using a 64­slice CT scanner (Phillips 
Brilliance 64, Eindhoven, Netherlands). We aimed at a 
biopsy angle as close to 90 degrees with respect to the 
pleura as possible. 
We used non­coaxial technique. The core needle bi­
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opsies were performed with an 18­gauge core needle 
(Angiotech, Stenløse, Denmark) (Figure 1). The tissue 
samples were placed on sterile millipore paper and sent 
for histological examination in a formalin suspension. 
The fine­needle aspirations were performed with a 0.8  
× 80 mm sterile needle (Sterican, Braun, Melsungen, 
Germany) and the tissue material was placed on object­
ive glass and sent for cytological examination.
Prior to the biopsies, all patients had a blood sam­
ple taken from which haemoglobin (Hgb) and coagula­
tion parameters were evaluated. The biopsy levels were 
set at Hgb concentration > 5 mmol/l, coagulation factor 
normal test (coagulation factor II, VII, X) > 0.4, activated 
partial thromboplastin time < 40 sec. and thrombocytes 
> 40 × 109/l. A lung function test was also performed and 
the biopsy level was set at a forced expiratory volume in 
the first sec. ≥ 1 l. The patients arrived at the hospitals’ 
Department of Pulmonary Medicine on the day of the 
biopsy. They were then escorted to the CT room at the 
Department of Radiology. After the biopsy, the patients 
returned to the Department of Pulmonary Medicine. 
The patients were observed for two hours and then an 
X­ray of the chest was performed. Patients without 
pneumothorax were dismissed from the hospital. 
Patients with pneumothorax were either observed 
overnight or, if treatment was needed, treated with 
drainage. Parenchymal bleeding seen on CT was not 
regis tered as a complication in the present study since 
none of the patients showed symptoms correlating with 
this feature. Patients with more than one complication 
were all registered with the most treatment­claiming 
complication. 
Patients with either haemoptysis or vasovagal 
symptoms together with a pneumothorax were regis­
tered as a pneumothorax complication. Patients with 
haemoptysis and vasovagal symptoms were registered 
as haemoptysis. One patient who died due to the pro­
ced ure and was registered as such, suffered from both 
pneumothorax and haemoptysis, and developed a car­
diac arrest following the procedure. 
The lesion size and the distance from the skin or 
pleura to the lesion were measured from the CT on the 
day of the biopsy. 
The calculation of pack­years used in the analysis 
was defined as daily number of cigarettes smoked,  
multiplied by years of smoking divided by 20.
statistics
Descriptive statistics were used, and p < 0.05 was con­
sidered statistically significant. Data were analysed with 
the Number Cruncher Statistical Systems (NCSS 8 statis­
tical software, Kaysville, UT, USA).
Trial registration: not relevant.
REsUlTs
Out of 444 successfully performed biopsies, the material 
was found to be malignant in 241 cases. Adenocarcin­
omas and squamous cell carcinomas were the most 
common malignant diagnoses (Table 1). 
The patient was a never­smoker in only 16 cases; 
and in 92 of the cases, the patient was a former smoker, 
the remaining patients were current smokers.
No small cell carcinomas or squamous cell carcin­
omas were found in biopsies from never­smokers or 
smokers with less than ten pack­years.
Out of the 520 biopsies, six cases were excluded as 
they had not been registered in the Web Pathology 
Register. In 444 (86%) out of 514 biopsies, the tissue ma­
terial was found to be sufficient (Table 2). As shown in 
Table 2, only the lesion size had a statistically significant 
influence on the successful completion of the biopsy. 
Complications were encountered in 33% (167 out of 
520) of the biopsies; 154 of these patients were diag­
nosed with a pneumothorax. In 15% (79 out of 520) of 
the biopsies, chest drainage was needed. A 73­year­old 
male with disseminated lung cancer and poor lung and 
cardiac function died immediately after the thorax bi­
opsy procedure.
Biopsies of patients with more than ten cigarette 
pack­years had a complication rate twice as high as bi­
opsies of patients with fewer pack­years (Table 3).
The complication rate and the need for treatment 
were clearly higher among smokers and former smokers 
FigURE 1
Computed tomography­guided core needle biopsy performed from a le­
sion in the left lung, with the patient in lateral position.
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than among never­smokers. Only 13% of the never­
smokers developed a pneumothorax compared with ap­
proximately 30% in the group of smokers and former 
smokers. Every fourth patient among the never­smokers 
required chest drainage, while this was the case in ap­
proximately every second patient in the group of smok­
ers or former smokers. We found an increased risk of 
developing a pneumothorax when the patient was bi­
opsied in a lateral position, p < 0.001 (Table 3), (Figure 
1). This may be due to the increased lung movement 
that occurs in this position. In a prone position, there is 
less lung movement. We found a significantly increased 
risk for developing a pneumothorax when the biopsy 
was obtaied 5­10 cm from the skin surface as compared 
with when it was obtained less than 5 cm from the skin 
surface (Table 3). There was also a higher risk of de­
veloping a pneumothorax when the lesions were less 
than 1 cm in diameter (Table 3). We found that every 
fourth male and every third female developed a pneu­
mothorax. Haemoptysis was also more common in fe­
males than in males (Table 3).
We performed a total of 93 re­biopsies or second 
re­biopsies. We did not find a higher incidence of com­
plications in these biopsies than in the remaining bi­
opsies.
discUssiOn
This study shows a correlation between certain risk fac­
tors and complications. We demonstrate that the com­
plication rate and the need for treatment are higher 
among smokers and former smokers with more than ten 
pack­years than among never­smokers. The risk of de­
veloping pneumothorax is also increased when the le­
sions are smaller or the biopsy route is long. We found 
an increased risk of pneumothorax when patients were 
biopsied in a lateral position. This is in line with the find­
ings reported in other studies [5­7]. We did not observe 
an increased risk of complications in patients with re­
duced lung function; but like Branden et al [5], we found 
an increased risk of treatment­dependent complications 
in patients with reduced lung function. This was also re­
ported by Yeow et al [4]. In the 520 biopsies reported in 
the present study, one was fatal due to cardiac arrest in 
a male multimorbid patient. This yields a mortality rate 
of 0.2% in the present study of CT­guided biopsies, 
which is in line with the rates reported in other studies 
[5].  Considering that patients who undergo lung bi­
opsies are typically not otherwise healthy, the risk of  
serious complications may be considered quite low. 
Other studies have reported similar results [5, 8].
The diagnostic yield depended on the lesion size as 
an improved yield was associated with increased lesion 
size (Table 2). This result is in line with those reported in 
other studies [3, 9, 10]. We found no small cell carcin­
omas or squamous cell carcinomas in the group of  
never­smokers or in the group of smokers with fewer 
than ten pack­years. Hence, these histological findings 
seem to be induced primarily by heavy smoking, which is 
in accordance with the observation made by Pesch et al 
[11].
TaBlE 1
Pathological diagnoses from 444 successfully performed computed  
tomography­guided biopsies.
diagnosis n
Adenocarcinoma 126
Small cell carcinoma   21
Squamous cell carcinoma   46
Metastases   21
Other malignant diagnoses   27
Non­malignant diagnoses 203
TaBlE 2
Diagnostic yield in computed tomography­guided biopsies. 
The values are n.
characteristic
successful 
biopsy
Failed 
biopsy p-value
Lesion size, cm 0.000001
< 1     9   6
1­4 276 54
> 4 159 10
Lesion localisation 0.5
Upper lobe 227 39
Lower lobe 188 26
Middle lobe   15   4
Thorax wall   14   1
Patient positioning 0.9
Prone 247 40
Supine 111 18
Lateral position   86 12
Lesion density 0.2
Semisolid 138 28
Cavitating   50   3
Solid 247 38
Ground glass opacity     9   1
Distance from skin 
surface to lesion, cm
0.3
≤ 2.5   12   1
2.6­5 166 21
5.1­10 250 43
10.1­15   16   5
Distance from parietal 
pleura to lesion, cm
0.3
0 181 24
0.1­1.9 131 16
2­3.9   98 19
4­5.9   26 11
6­18     8   0
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The planning of the biopsy path is very important in 
minimising the complication rate and also to reduce the 
necessary exposure time [12]. The planning includes 
finding the shortest distance to the lesion, avoiding ves­
sels and airways, and avoiding to cross the interlobar 
spaces. This approach will contribute to keep low the oc­
currence of complications like pneumothorax and haem­
orrhage, and it will minimise the rate of seeding. Earlier 
studies, however, have not shown any increase in  
pleural carcinomatosis when transthoracic biopsies are 
compared with transbronchial biopsies [13, 14]. Flechsig 
found only one out of 146 cases with possible seeding in 
the thorax wall after biopsy. Although it is seldom, seed­
ing must be avoided whenever possible. This is why it is 
essential to avoid biopsies across interlobar spaces.
An earlier study has reported only a non­significant 
difference between complications recorded when using 
coaxial and non­coaxial techniques, respectively [6]. The 
authors found complicating pneumothorax in 36.6% of 
the biopsies that were done with the coaxial technique 
and 32.3% in biopsies done using the non­coaxial tech­
nique. In our study, we used only the non­coaxial tech­
nique, and our complication rate was equal to that re­
ported in the Nour­Eldin study. However, in cases in 
which the nodule is very small, the first specimen can be 
insufficient for pathological examination; an extra biopsy 
may therefore be needed. In these cases, the use of a 
coaxial needle could be an advantage. The main limita­
tion of the present study is that it is not a prospective 
study, which makes it dependent on information already 
available in the databases. This left us with some unan­
swered questions, for instance concerning smoking hab­
its, co­morbidity and lung function. Furthermore, we did 
not register the pathological findings in patients who  
underwent a lung resection although the primary bi­
opsies did not show malignant findings. Nonetheless, we 
were able to get most of the information concerning the 
actual biopsy procedure because we had access to all 
the CTs. The strength of this study is the inclusion of a 
very large number of patients.
For the patients, the period after the biopsy can be 
associated with a degree of pain [15], which is usually 
well­tolerated. However, we did not monitor pain in this 
retrospective study, nor did we monitor the exact level 
of radiation that the radiologist received during the bi­
opsy. We did, nevertheless, occasionally measure the ra­
diologist’s exact hand dose in the last part of the study 
and introduced sterile radiation­reducing gloves to pro­
tect the fingertips, which are at risk of being exposed to 
the highly collimated CT beams. A study [16] has shown 
that the median hand dose in CT­guided interventions 
was 0.22 mSv and the study concluded that the upper 
limit for the annual hand dose will normally first be 
reached at approximately 2,000 annual interventions. 
In the future, the need for biopsies with histological 
specimens will increase, although a recent systematic 
review has shown a similar, high sensitivity and specifi­
city of core needle biopsies and fine­needle aspiration in 
distinguishing benign from malignant pulmonary lesions 
[17]. Furthermore, distinguishing between the histo­
logical subtypes of the malignant lesions. Owing to the 
fact that chemotherapeutic treatment is getting more 
and more specific. This aims for core needle biopsies 
rather than fine needle aspirations, shown by Choi et al 
[9] and also recognised in other studies [10, 18]. When 
TaBlE 3
Risk and complication factors in computed tomography­guided biopsies. The values are n.
complications no
characteristic pneumothorax haemoptysis other complications p-value
Gender
Male
Female
  71
  83
0.02
  2
10
1
0
207
146
Age, yrs
20­49
50­59
60­69
70­79
80­92
    9
  23
  49
  52
  21
  1
  2
  3
  5
  1
0
0
0
1
0
    9
  62
134
108
  40
NS
Cigaret pack-yearsa
< 10
≥ 10
  12
128
  4
  6
0
1
  61
260
0.02
Lung disease
Yes
No
  39
115
  1
11
1
0
  64
289
NS
Patient positioning
Prone
Supine
Lateral position
  74
  35
  45
  6
  3
  3
1
0
0
209
  92
  52
0.0007
 
Lesion localisation
Upper lobe
Lower lobe
Middle lobe
Thorax wall
 
 97
  46
  11
    0
10
  2
  0
  0
0
1
0
0
162
168
    8
  15
0.00001
Thorax half
Right
Left
  92
  62
  3
  9
1
0
176
177
NS
Distance from skin 
surface to lesion, cm
≤ 2.5
2.6­5
5.1­10
10.1­15
    0
  38
108
    8
  0
  3
  6
  3
0
0
1
0
  13
146
183
  11
0.00001
Distance from parietal 
pleura to lesion, cm
0
0.1­1.9
2.0­3.9
4.0­5.9
6.0­18.0
  23
  54
  51
  23
    3
  2
  3
  5
  2
  0
0
1
0
0
0
180
  92
  62
  13
    6
0.00001
Lesion size, cm
< 1
1­5
> 5
    8
130
  16
  0
12
  0
0
1
0
    7
236
110
0.00001
NS = non­significant.
a) In 48 cases out of the 520 biopsies there were no information about pack­years.
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performing biopsy of ground glass opacities, even core 
needle biopsies are in many cases insufficient in those 
cases where determination of the specific cell type of 
the tumour is essential for treatment planning. In their 
study from 2013 [19], Yamagami et al showed that the 
correct specific cell type was revealed in only 55% of the 
biopsies compared with an operative sampling.
cOnclUsiOns
CT­guided thorax biopsy is a safe diagnostic procedure 
for obtaining histological and cytological material before 
treatment and carries only a low risk of serious complica­
tions. The risk of complications can be estimated from 
patient smoking habits, lesion size, location of the lesion, 
biopsy depth, positioning of the patient and gender.
This study clearly shows that the risk of developing 
a pneumothorax is significantly higher among smokers 
and former smokers with more than ten pack­years than 
among never­smokers. The risk of pneumothorax rises 
the further the lesion is located from the skin surface 
and the smaller the lesion is.
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